1887
Research article Open Access
Like 0

Abstract

Plaque reduction neutralisation tests (PRNT), microneutralisation (MN), Middle East respiratory syndrome (MERS)-spike pseudoparticle neutralisation (ppNT) and MERS S1-enzyme-linked immunosorbent assay (ELISA) antibody titres were compared using 95 sera from 17 patients with MERS, collected two to 46 days after symptom onset. Neutralisation tests correlated well with each other and moderately well with S1 ELISA. Moreover to compare antigenic similarity of genetically diverse MERS-CoV clades, the response of four sera from two patients sampled at two time periods during the course of illness were tested by 90% PRNT. Genetically diverse MERS-CoV clades were antigenically homogenous.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2015.20.41.30042
2015-10-15
2017-12-12
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2015.20.41.30042
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/20/41/eurosurv-20-30042-3.html?itemId=/content/10.2807/1560-7917.ES.2015.20.41.30042&mimeType=html&fmt=ahah

References

  1. World Health Organization (WHO). WHO statement on the tenth meeting of the IHR Emergency Committee regarding MERS. Geneva: WHO; September 3, 2015. [Accessed 12 Sep 2015]. Available from: http://www.who.int/mediacentre/news/statements/2015/ihr-emergency-committee-mers/en/
  2. World Health Organization (WHO). Laboratory testing for Middle East Respiratory Syndrome Coronavirus. Interim guidance (revised). Geneva: WHO; June 2015. [Accessed 11 Sep 2015]. Available from: http://apps.who.int/iris/bitstream/10665/176982/1/WHO_MERS_LAB_15.1_eng.pdf?ua=1
  3. Müller MA, Meyer B, Corman VM, Al-Masri M, Turkestani A, Ritz D, et al. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis. 2015;15(5):559-64.  https://doi.org/10.1016/S1473-3099(15)70090-3  PMID: 25863564 
  4. Meyer B, Drosten C, Müller MA. Serological assays for emerging coronaviruses: challenges and pitfalls. Virus Res. 2014;194:175-83.  https://doi.org/10.1016/j.virusres.2014.03.018  PMID: 24670324 
  5. Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, et al. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 2013;18(36):20574.  https://doi.org/10.2807/1560-7917.ES2013.18.36.20574  PMID: 24079378 
  6. Spanakis N, Tsiodras S, Haagmans BL, Raj VS, Pontikis K, Koutsoukou A, et al. Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen. Int J Antimicrob Agents. 2014;44(6):528-32.  https://doi.org/10.1016/j.ijantimicag.2014.07.026  PMID: 25288266 
  7. de Sousa R, Reusken C, Koopmans M. MERS coronavirus: data gaps for laboratory preparedness. J Clin Virol. 2014;59(1):4-11.  https://doi.org/10.1016/j.jcv.2013.10.030  PMID: 24286807 
  8. Park HY, Lee EJ, Ryu YW, Kim Y, Kim H, Lee H, et al. Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Euro Surveill. 2015;20(25):1-6.  https://doi.org/10.2807/1560-7917.ES2015.20.25.21169  PMID: 26132766 
  9. Park WB, Perera RA, Choe PG, Lau EH, Choi SJ, Chun JY, et al. Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea. Emerg Infect Dis. 2015;21(12).  https://doi.org/10.3201/eid2112.151421 
  10. Chan RW, Hemida MG, Kayali G, Chu DK, Poon LL, Alnaeem A, et al. Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study. Lancet Respir Med. 2014;2(10):813-22.  https://doi.org/10.1016/S2213-2600(14)70158-4  PMID: 25174549 
  11. Hemida MG, Perera RA, Al Jassim RA, Kayali G, Siu LY, Wang P, et al. Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill. 2014;19(23):20828.  https://doi.org/10.2807/1560-7917.ES2014.19.23.20828  PMID: 24957744 
  12. Drosten C, Meyer B, Müller MA, Corman VM, Al-Masri M, Hossain R, et al. Transmission of MERS-coronavirus in household contacts. N Engl J Med. 2014;371(9):828-35.  https://doi.org/10.1056/NEJMoa1405858  PMID: 25162889 
  13. Hemida MG, Al-Naeem A, Perera RA, Chin AW, Poon LL, Peiris M. Lack of middle East respiratory syndrome coronavirus transmission from infected camels. Emerg Infect Dis. 2015;21(4):699-701.  https://doi.org/10.3201/eid2104.141949  PMID: 25811546 
  14. Buchy P, Vong S, Chu S, Garcia JM, Hien TT, Hien VM, et al. Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus. PLoS ONE. 2010;5(5):e10864.  https://doi.org/10.1371/journal.pone.0010864  PMID: 20532246 
  15. Muth D, Corman VM, Meyer B, Assiri A, Al-Masri M, Farah M, et al. Infectious Middle East Respiratory Syndrome Coronavirus Excretion and Serotype Variability Based on Live Virus Isolates from Patients in Saudi Arabia. J Clin Microbiol. 2015;53(9):2951-5.  https://doi.org/10.1128/JCM.01368-15  PMID: 26157150 
/content/10.2807/1560-7917.ES.2015.20.41.30042
Loading

Data & Media loading...

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error